Reference health

CREB expression mediates amyloid β-induced basal BDNF downregulation

https://doi.org/10.1016/j.neurobiolaging.2015.04.014
CiteStamped reference-health badge
53/53 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

1 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 53 checked references that resolve
resolves10.2174/157015911798376190
The Neurotrophins and Their Role in Alzheimers Disease
resolves10.1002/jnr.10443
Animal model of dementia induced by entorhinal synaptic damage and partial restoration of cognitive deficits by BDNF and carnitine
resolves10.1042/BJ20070797
The selectivity of protein kinase inhibitors: a further update
resolves10.1517/14728222.7.1.101
CREB, memory enhancement and the treatment of memory disorders: promises, pitfalls and prospects
resolves10.1073/pnas.0901402106
Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease
resolves10.1073/pnas.1012851108
CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer's disease
resolves10.1016/j.mcn.2011.11.003
Suppression of aggregate formation of mutant huntingtin potentiates CREB-binding protein sequestration and apoptotic cell death
resolves10.1016/0197-4580(87)90127-8
Neuron numbers and dendritic extent in normal aging and Alzheimer's disease
resolves10.1016/j.neurobiolaging.2003.09.001
Synaptic slaughter in Alzheimer's disease
resolves10.1016/S0169-328X(97)00125-3
Brain-derived neurotrophic factor is reduced in Alzheimer's disease
resolves10.1016/j.nbd.2011.09.002
Activation of glycogen synthase kinase-3 beta mediates β-amyloid induced neuritic damage in Alzheimer's disease
resolves10.1046/j.1471-4159.2000.0750991.x
Sequential Treatment of SH‐SY5Y Cells with Retinoic Acid and Brain‐Derived Neurotrophic Factor Gives Rise to Fully Differentiated, Neurotrophic Factor‐Dependent, Human Neuron‐Like Cells
resolves10.1523/JNEUROSCI.2154-10.2010
 -Amyloid Disrupts Activity-Dependent Gene Transcription Required for Memory through the CREB Coactivator CRTC1
resolves10.2217/fnl.11.44
Brain-Derived Neurotrophic Factor: the Link Between Amyloid-β and Memory Loss
resolves10.1016/j.neurobiolaging.2010.03.019
BDNF increases with behavioral enrichment and an antioxidant diet in the aged dog
resolves10.1002/jnr.1086
BDNF dependence in neuroblastoma
resolves10.1080/15216540701283882
Soluble protein oligomers as emerging toxins in alzheimer's and other amyloid diseases
resolves10.1097/00005072-199907000-00007
BDNF and Full-length and Truncated TrkB Expression in Alzheimer Disease. Implications in Therapeutic Strategies
resolves10.1016/j.neurobiolaging.2010.04.003
Object recognition memory and BDNF expression are reduced in young TgCRND8 mice
resolves10.1046/j.1471-4159.2002.01030.x
A new brain‐derived neurotrophic factor transcript and decrease inbrain‐derived neurotrophic factor transcripts 1, 2 and 3 in Alzheimer's disease parietal cortex
resolves10.1523/JNEUROSCI.5053-06.2007
Oligomeric Amyloid Decreases Basal Levels of Brain-Derived Neurotrophic factor (BDNF) mRNA via Specific Downregulation of BDNF Transcripts IV and V in Differentiated Human Neuroblastoma Cells
resolves10.1385/JMN:17:2:137
Intracellular Mechanisms of Amyloid Accumulation and Pathogenesis in Alzheimer's Disease
resolves10.1046/j.1471-4159.2001.00495.x
CREB DNA binding activity is inhibited by glycogen synthase kinase‐3β and facilitated by lithium
resolves10.1126/science.1072994
The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics
resolves10.1001/archneur.57.6.846
Region-Specific Neurotrophin Imbalances in Alzheimer Disease
resolves10.1016/S0169-328X(00)00023-1
Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer's disease
resolves10.1016/j.jalz.2011.10.007
National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
resolves10.1097/00005072-199710000-00002
Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease
resolves10.1016/0896-6273(93)90187-V
Induction of TrkB by retinoic acid mediates biologic responsiveness to BDNF and differentiation of human neuroblastoma cells
resolves10.1371/journal.pone.0035678
Tau-Mediated Nuclear Depletion and Cytoplasmic Accumulation of SFPQ in Alzheimer's and Pick's Disease
resolves10.1523/JNEUROSCI.3501-06.2007
Aβ Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease
resolves10.1002/jnr.490390404
β/A4‐evoked degeneration of differentiated SH‐SY5Y human neuroblastoma cells
resolves10.1101/lm.54603
BDNF and Activity-Dependent Synaptic Modulation: Figure 1.
resolves10.1212/WNL.34.7.939
Clinical diagnosis of Alzheimer's disease
resolves10.1016/S0169-328X(03)00003-2
Pro-brain-derived neurotrophic factor is decreased in parietal cortex in Alzheimer’s disease
resolves10.1523/JNEUROSCI.5195-12.2013
Early BDNF Treatment Ameliorates Cell Loss in the Entorhinal Cortex of APP Transgenic Mice
resolves10.1038/nm.1912
Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease
resolves10.1523/JNEUROSCI.4736-08.2009
Decreased Brain-Derived Neurotrophic Factor Depends on Amyloid Aggregation State in Transgenic Mouse Models of Alzheimer's Disease
resolves10.1111/j.1471-4159.2005.03135.x
Precursor form of brain‐derived neurotrophic factor and mature brain‐derived neurotrophic factor are decreased in the pre‐clinical stages of Alzheimer's disease
resolves10.1016/0896-6273(91)90273-3
BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease
resolves10.1016/j.ygeno.2007.05.004
Dissecting the human BDNF locus: Bidirectional transcription, complex splicing, and multiple promoters
resolves10.1523/JNEUROSCI.4540-10.2011
Identification of<i>cis</i>-Elements and Transcription Factors Regulating Neuronal Activity-Dependent Transcription of Human<i>BDNF</i>Gene
resolves10.1186/1750-1326-6-60
Downregulation of CREB expression in Alzheimer's brain and in Aβ-treated rat hippocampal neurons
resolves10.1002/jnr.23512
Calcitonin gene‐related peptide regulation of glial cell‐line derived neurotrophic factor in differentiated rat myotubes
resolves10.1016/j.neurobiolaging.2003.08.002
Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies
resolves10.1016/S0896-6273(00)81011-9
Identification of a Signaling Pathway Involved in Calcium Regulation of BDNF Expression
resolves10.1016/S0896-6273(00)81010-7
Ca2+ Influx Regulates BDNF Transcription by a CREB Family Transcription Factor-Dependent Mechanism
resolves10.1523/JNEUROSCI.5463-03.2004
β-Amyloid Peptide at Sublethal Concentrations Downregulates Brain-Derived Neurotrophic Factor Functions in Cultured Cortical Neurons
resolves10.1074/jbc.M010450200
β-Amyloid-(1–42) Impairs Activity-dependent cAMP-response Element-binding Protein Signaling in Neurons at Concentrations in Which Cell Survival Is Not Compromised
resolves10.1073/pnas.172504199
Amyloid β-peptide inhibition of the PKA/CREB pathway and long-term potentiation: Reversibility by drugs that enhance cAMP signaling
resolves10.1111/j.1471-4159.2006.04426.x
Aβ Oligomers – a decade of discovery
resolves10.1016/S0166-2236(99)01500-3
Is CREB a key to neuronal survival?
resolves10.1006/abio.1994.1356
Use of a Synthetic Peptide as a Selective Substrate for Glycogen Synthase Kinase 3
The 1 reference without a DOI — listed, not checked
no DOI — not checkedForskolin: a unique diterpene activator of cyclic AMP-generating systems
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1016/j.neurobiolaging.2015.04.014"><img src="https://citestamp.com/citestamped/10.1016/j.neurobiolaging.2015.04.014/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1016/j.neurobiolaging.2015.04.014/badge.svg)](https://citestamp.com/citestamped/10.1016/j.neurobiolaging.2015.04.014)